Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01640951
What this trial is testing

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-Type Psoriasis
Novartis Pharmaceuticals 675
Testing effectiveness (Phase 2)Ended earlyNCT04739358
What this trial is testing

CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC

Who this might be right for
Advanced Non-Small Cell Lung Cancer With MET Mutations
Criterium, Inc. 2
Not applicableStudy completedNCT00873652
What this trial is testing

Observational Study of Immune Response to Hepatitis B Childhood Booster

Who this might be right for
Healthy
University of Oxford 28
Early research (Phase 1)Study completedNCT01335269
What this trial is testing

BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 96
Testing effectiveness (Phase 2)Study completedNCT05007080
What this trial is testing

Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive

Who this might be right for
Coronavirus Disease-2019 (COVID-19) Prevention
Janssen Vaccines & Prevention B.V. 304
Testing effectiveness (Phase 2)Study completedNCT03347188
What this trial is testing

Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)

Who this might be right for
Post-Traumatic Headache
Teva Branded Pharmaceutical Products R&D, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT01405677
What this trial is testing

Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine

Who this might be right for
Hepatitis A
Crucell Holland BV 308
Large-scale testing (Phase 3)Active Not RecruitingNCT06824194
What this trial is testing

Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Who this might be right for
Pneumococcal Immunization
Sanofi 2,360
Post-approval studies (Phase 4)Study completedNCT00483379
What this trial is testing

High Dose or High Dose Frequency Study of Alglucosidase Alfa

Who this might be right for
Pompe DiseaseGlycogen Storage Disease Type II (GSD-II)Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company 13
Testing effectiveness (Phase 2)Study completedNCT03981822
What this trial is testing

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

Who this might be right for
Condylomata AcuminataPapillomavirus InfectionsSkin Diseases, Viral+5 more
Verrica Pharmaceuticals Inc. 105
Testing effectiveness (Phase 2)Looking for participantsNCT05501327
What this trial is testing

Dose Regimen Study of SLI-F06 in Healthy Volunteers

Who this might be right for
ScarWound Healing
Scarless Laboratories, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01279473
What this trial is testing

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 42
Early research (Phase 1)Study completedNCT00400296
What this trial is testing

R547 in Patients With Advanced Solid Tumors.

Who this might be right for
Neoplasms
Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Study completedNCT00111839
What this trial is testing

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

Who this might be right for
Lung CancerNon Small Cell Lung Carcinoma
EMD Serono 150
Not applicableEnded earlyNCT00235781
What this trial is testing

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Washington University School of Medicine 90
Testing effectiveness (Phase 2)Study completedNCT00729001
What this trial is testing

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 529
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07609472
What this trial is testing

FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma

Who this might be right for
High-Grade Glioma (WHO III-IV)
FluoGuide A/S 76
Post-approval studies (Phase 4)Study completedNCT00778999
What this trial is testing

Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)

Who this might be right for
Infertility
Organon and Co 442
Testing effectiveness (Phase 2)Study completedNCT03566940
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 302
Early research (Phase 1)Study completedNCT00419250
What this trial is testing

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaLeukemia, B-Cell, Chronic
Celgene 52
Next Page